期刊文献+

益生菌临床应用的研究进展 被引量:11

Research progress of probiotics in clinical application
原文传递
导出
摘要 近年来,研究发现多种疾病的发生与肠道菌群失调密切相关,而益生菌在维持肠道菌群平衡中起重要作用。益生菌在预防和治疗腹泻、肥胖、肝脏损伤、肿瘤等疾病中展示良好的效果,其临床制剂的开发已成为当前研究的热点。随着益生菌制剂的广泛使用,益生菌可能带来的不良反应也需要得到重视。本文阐述了益生菌制剂对疾病的预防、治疗及不良反应的研究进展,旨在为益生菌精准治疗及拓展益生菌临床应用提供理论依据。 Probioties play an important role in maintaining the balance of intestinal flora. More and more studies have found that the occurrence of multiple diseases is closely related to intestinal flora imbalance. Therefore, the development of probiotics clinical agents has become the focus of current research. The studies have found that probiotics have good effects in the treatment and prevention of diarrhea, obesity, liver injury, cancers and other diseases. With the widespread use of probiotics clinical agents, the adverse effects of probiotics should be paid attention. Advances of probiotics in the prevention, treatment of diseases and its adverse reactions are described in this paper in order to provide a theoretical basis for the accurate treatment and expanding the clinical application of probiotics.
作者 何小平 张孟 戴承恩 郑芬芬 李海龙 HE Xiao-ping1,2, ZHANG Meng1, DAI Cheng-en1, ZHENG Fen-fen1, LI Hai-long1(1. Zhejiang Yalin Biotechnology Co., Ltd., Hangzhou ZHEJIANG 311400, China; 2. Research Institute of Subtropical Forestry, Chinese Academy of Forestry, Hangzhou ZHEJIANG 311400, Chin)
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2018年第3期130-135,共6页 Chinese Journal of New Drugs and Clinical Remedies
关键词 有益菌种 肠道菌群 腹泻 药物毒性 临床应用 probiotics intestinal microflora diarrhea drug toxicity clinical application
  • 相关文献

参考文献5

二级参考文献115

  • 1董珂,刘晶星,郭晓奎.益生菌增强机体免疫和抗肿瘤作用的分子机制[J].中国微生态学杂志,2005,17(1):79-80. 被引量:28
  • 2师延明,王美清,马永寿,郭金艳.微生态制剂预防新生儿抗生素相关性腹泻的Meta分析[J].中国微生态学杂志,2006,18(3):252-254. 被引量:33
  • 3WESTON S, HALBERT A, RICHMOND P, et al. Effects of probiotics on atopic dermatitis: a randomised controlled trial [J]. Arch Dis Child ,2005,90(9) :892-897.
  • 4BESSELINK M G,van SANTVOORT H C, BUSKENS E,et al. Boer-Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial [J]. Lancet, 2008, 371 (9613) :651-659.
  • 5Food and Agriculture Organization of the United Nations and World Health Organization (FAO-WHO) (2002). Guideline for the evaluation of probioties in food [P]. FAO of the United Nations and WHO working group report; Online:http://who. int/foodsafety/publications. fs-management/probioties/en/
  • 6SALMINEN S, ARVILOMMI H. Probiotic demonstrating efficacy in clinical setting [J]. Clin lnfrct Dis,2001,32 ( 6 ) : 1577 -1578.
  • 7LIVIN-LE MOAL V, SARRAZIN-DAVILA L E, SERVIN A L. An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonmtavirus diarrhea[J]. Pediatrics,2007, 120(4) :795-803.
  • 8DROUAULT-HOLOWACZ S, BIEUVELET S, BURCKEL A,et al. A double blind randomized controlled trial of a probiofic combination in 100 patients with irritable bowel syndrome[J]. Gastroenterol Clin Biol, 2008,32 (2) : 147-152.
  • 9GEIER M S, BUTLER R N, HOWARTH G S. Inflammatory bowel disease: current insights into pathogenesis and newtherapeutic options; probiotics, prebiotics and synbiotics [ J ]. Int J Food Microbiol,2007, 115(1):1-11.
  • 10IMASE K, TANAKA A,TOKUNAGA K, et al. Lactobacillus reuteri tablets suppress Helicobacter pylori infection-adouble-blind randomised placebo-controlled cross-over clinical study [J]. Kansenshogaku Zasshi ,2007,81 (4) : 387-393.

共引文献95

同被引文献145

引证文献11

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部